Nicholas J. Mourlas , PhD

Director
XIG
Xerox Corporation
Palo Alto, CA

Nicholas Mourlas is PARC's Director of Global Healthcare Innovation and Xerox Innovation Group Healthcare Program Manager at Xerox. His focus is developing and executing a high-impact innovation strategy that aligns with the long-term roadmap of the Xerox healthcare businesses. He is responsible for identifying and understanding emerging trends in healthcare and technology that affect the healthcare roadmap in collaboration with the Chief Innovation Officer. He currently serves on the Boards of Directors of Siris Medical, and Akros Medical. Previously, Dr. Mourlas was the CEO of Tarsus Medical - acquired by Integra LifeSciences (IART), and Acumen Medical - acquired by Medtronic (MDT). Dr. Mourlas holds a Ph.D. in Electrical Engineering from Stanford University where he was the John B. Simpson Biomedical Innovation Technology Fellow in the inaugural year of Stanford's Biodesign Fellowship Program. He received his AB in Engineering Sciences from Dartmouth College, and a BE from Dartmouth's Thayer School. He regularly guest lectures at Dartmouth College and Stanford on the topic of medical device innovation.